pI: 10.3401 |
Length (AA): 101 |
MW (Da): 11714 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
11 | 99 | 1th7 (A) | 3 | 78 | 32.00 | 0 | 1 | 1.15 | -0.3 |
17 | 100 | 1b34 (B) | 27 | 113 | 72.00 | 0 | 1 | 1.5 | -0.92 |
1 | 101 | 4pjo (D) | 11 | 114 | 60.00 | 0 | 1 | 1.6786 | -0.58 |
2 | 99 | 3pgw (Y) | 8 | 112 | 66.00 | 0 | 1 | 1.6142 | 0.37 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, merozoite, sporozoite, early ring, early trophozoite, late ring, late trophozoite, Oocyst, Ring, Female Gametocyte, Male Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 48 hs, early schizont, late schizont. | Otto TD PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 40 hs, Sporozoite. | Otto TD Zanghi G |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Ortholog group members (OG5_127733)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G62840 | small nuclear ribonucleoprotein D2 |
Arabidopsis thaliana | AT2G47640 | small nuclear ribonucleoprotein D2 |
Babesia bovis | BBOV_I004230 | small nuclear ribonucleoprotein, putative |
Brugia malayi | Bm1_52920 | Chain B, Crystal Structure Of The D1d2 Sub-Complex From The Human Snrnp Core Domain. |
Caenorhabditis elegans | CELE_C52E4.3 | Protein SNR-4 |
Cryptosporidium hominis | Chro.40363 | small nuclear ribonucleoprotein |
Cryptosporidium parvum | cgd4_3190 | small nuclear ribonucleoprotein |
Dictyostelium discoideum | DDB_G0285395 | LSM domain-containing protein |
Drosophila melanogaster | Dmel_CG1249 | Small ribonucleoprotein particle protein SmD2 |
Echinococcus granulosus | EgrG_000458700 | small nuclear ribonucleoprotein Sm |
Entamoeba histolytica | EHI_108640 | LSM domain containing protein |
Echinococcus multilocularis | EmuJ_000458700 | small nuclear ribonucleoprotein Sm |
Giardia lamblia | GL50803_32297 | Small nuclear ribonucleoprotein Sm D2, putative |
Homo sapiens | ENSG00000125743 | small nuclear ribonucleoprotein D2 polypeptide 16.5kDa |
Leishmania braziliensis | LbrM.33.3460 | small nuclear ribonucleoprotein SmD2 |
Leishmania donovani | LdBPK_333340.1 | small nuclear ribonucleoprotein SmD2 |
Leishmania infantum | LinJ.33.3340 | small nuclear ribonucleoprotein SmD2 |
Leishmania major | LmjF.33.3190 | small nuclear ribonucleoprotein SmD2 |
Leishmania mexicana | LmxM.32.3190 | small nuclear ribonucleoprotein SmD2 |
Loa Loa (eye worm) | LOAG_06277 | small Nuclear Ribonucleoprotein family member |
Mus musculus | 107686 | small nuclear ribonucleoprotein D2 |
Neospora caninum | NCLIV_035950 | hypothetical protein |
Oryza sativa | 4338385 | Os05g0314100 |
Plasmodium berghei | PBANKA_0315200 | small nuclear ribonucleoprotein Sm D2, putative |
Plasmodium falciparum | PF3D7_0218500 | small nuclear ribonucleoprotein Sm D2, putative |
Plasmodium knowlesi | PKNH_0402400 | small nuclear ribonucleoprotein Sm D2, putative |
Plasmodium vivax | PVX_002615 | small nuclear ribonucleoprotein Sm D2, putative |
Plasmodium yoelii | PY01248 | small nuclear ribonucleoprotein. |
Saccharomyces cerevisiae | YLR275W | Smd2p |
Schistosoma japonicum | Sjp_0055670 | Probable small nuclear ribonucleoprotein Sm D2, putative |
Schistosoma mansoni | Smp_075560 | small nuclear ribonucleoprotein Sm D2 |
Schmidtea mediterranea | mk4.003577.06 | Probable small nuclear ribonucleoprotein Sm D2 |
Schmidtea mediterranea | mk4.004232.01 | Probable small nuclear ribonucleoprotein Sm D2 |
Trypanosoma brucei gambiense | Tbg.972.2.4110 | small nuclear ribonucleoprotein SmD2 |
Trypanosoma brucei | Tb927.2.5850 | small nuclear ribonucleoprotein SmD2 |
Trypanosoma congolense | TcIL3000_2_1520 | small nuclear ribonucleoprotein SmD2, putative |
Trypanosoma cruzi | TcCLB.511189.80 | small nuclear ribonucleoprotein SmD2, putative |
Trypanosoma cruzi | TcCLB.508667.49 | small nuclear ribonucleoprotein SmD2, putative |
Toxoplasma gondii | TGME49_270830 | small nuclear ribonucleoprotein |
Theileria parva | TP02_0729 | small nuclear ribonucleoprotein D2, putative |
Trichomonas vaginalis | TVAG_472580 | small nuclear ribonucleoprotein sm D2, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.2.5850 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.2.5850 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.2.5850 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.2.5850 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C52E4.3 | Caenorhabditis elegans | embryonic arrest | wormbase |
CELE_C52E4.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C52E4.3 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C52E4.3 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C52E4.3 | Caenorhabditis elegans | sterile | wormbase |
YLR275W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0315200 | Plasmodium berghei | Dispensable | plasmo |
TGME49_270830 | Toxoplasma gondii | Probably essential | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.